Haemonetics Corporation Profile Avatar - Palmy Investing

Haemonetics Corporation

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, inc…

Medical - Instruments & Supplies
US, Boston [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2014 0.6800 2.010 938 909 35 34 47 116 47 47 366 351
2015 0.3300 1.899 910 922 16 31 40 132 40 43 339 355
2016 -1.0900 1.727 909 911 -55 -49 126 60 36 -25 323 301
2017 -0.5100 1.517 886 876 -26 6 128 110 39 21 301 304
2018 0.8600 1.868 903 898 45 -18 145 44 56 -19 316 257
2019 1.0700 2.334 967 968 55 44 192 158 83 68 298 265
2020 1.5100 3.343 988 995 76 63 264 167 153 80 299 234
2021 1.5700 2.563 870 868 79 89 142 194 57 114 274 255
2022 0.8500 2.532 993 986 43 -3 169 139 71 30 339 313
2023 2.2700 2.967 1,168 1,154 115 43 249 215 156 106 376 329
2024 - 3.959 - 1,295 - 114 - 237 - 117 - 362
2025 - 4.592 - 1,396 - 236 - 292 - 164 - 447
2026 - 2.F12X/td> - 2.F12X/td> - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 1.F13X/td> - 1.F13X/td> - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 0.F14X/td> - 0.F14X/td> - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
End of HAE's Analysis
CIK: 313143 CUSIP: 405024100 ISIN: US4050241003 LEI: - UEI: -
Secondary Listings
HAE has no secondary listings inside our databases.